Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The association between intron 4 VNTR, E298A and IVF 23+10 G/T polymorphisms of ecNOS gene and sildenafil responsiveness in patients with erectile dysfunction

Abstract

The objective of the study was to determine the association between intron 4 variable number of tandem repeats (VNTR), E298A and IVF 23+10 G/T polymorphisms of ec-NOS gene and sildenafil responsiveness in patients with erectile dysfunction (ED). Ninety-six patients who were evaluated for ED between November 2003 and June 2004 and 167 healthy individuals representing the normal population as controls were included in the present study. The patients were evaluated by medical history, five-item version of International Index of Erectile Function, serum glucose, testosterone levels and lipid profiles. Sixty-seven patients received four consecutive doses of sildenafil from 25 to 100 mg according to the response. The ec-NOS gene intron 4 VNTR, E298A and IVF 23+10 G/T polymorphisms were evaluated in the isolated DNA blood samples obtained from the patient group with ED (n=96), from the group received sildenafil (n=67) and from the healthy group (n=167). Genotype distributions of ec-NOS gene intron 4, E298A and IVF 23+10 G/T polymorphisms in the patient group were similar to those in the healthy group. The frequency of the ec-NOS gene intron 4 genotype were found as bb=41.7%, ab=50% and aa=8.3% in the sildenafil responders and bb=93.5% and ba=6.5% in the sildenafil non-responders. This finding was statistically significant. Statistical analysis of ec-NOS gene E298A and IVF 23+10 G/T polymorphisms did not reveal any significant difference between sildenafil responders and non-responders. These findings may indicate that ‘a’ allele of ec-NOS gene intron 4 VNTR polymorphism associates with a better sildenafil response.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Melman A, Gingell JC . The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5–11.

    Article  CAS  Google Scholar 

  2. Murray FT, Geisser M, Murphy TC . Evaluation and treatment of erectile dysfunction. Am J Med Sci 1995; 309: 99–109.

    Article  CAS  Google Scholar 

  3. Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J . Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990; 31: 843–850.

    Article  Google Scholar 

  4. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ . Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326: 90–94.

    Article  CAS  Google Scholar 

  5. Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH . Nitric oxide: a physiological mediator of penile erection. Science 1992; 257: 401–403.

    Article  CAS  Google Scholar 

  6. Rajasekaran M, Mondal D, Agrawal K, Chen IL, Hellstrom W, Sikka S . Ex vivo expression of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile cavernosal cells. J Urol 1998; 160: 2210–2215.

    Article  CAS  Google Scholar 

  7. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro L . Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosamine. J Cyclic Nucleotide Res 1979; 5: 211–224.

    CAS  PubMed  Google Scholar 

  8. Ignarro LJ . Introduction and overview. In: Ignarro LJ (ed). Nitric oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 1–19.

    Google Scholar 

  9. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA . Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397–1404.

    Article  CAS  Google Scholar 

  10. Masters BS . Structural variations to accommodate functional themes of the isoforms of NO synthases. In: Ignarro LJ (ed). Nitric Oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 91–104.

    Chapter  Google Scholar 

  11. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.

    Article  CAS  Google Scholar 

  12. Eisenhardt A, Sperling H, Hauck E, Porst H, Stief C, Rubben C et al. ACE gene I/D and NOS 3 G 894T polymorphisms and response to sildenafil in men with erectile dysfunction. Urology 2003; 62: 152–157.

    Article  Google Scholar 

  13. Miller SA, Dykes DD, Polesky HS . Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1998; 20: 1433–1440.

    Google Scholar 

  14. Yoon Y, Song J, Hong S, Kim J . Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000; 46: 1626–1630.

    CAS  PubMed  Google Scholar 

  15. Vernet D, Cai L, Garban H, Babbitt ML, Murray FT, Rajfer J et al. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type II) rats with erectile dysfunction. Endocrinology 1995; 136: 5709–5717.

    Article  CAS  Google Scholar 

  16. De Meyer GRY, Herman AG . Nitric oxide and vascular endothelial dysfunction. In: Ignarro LJ (ed). Nitric oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 547–567.

    Chapter  Google Scholar 

  17. Balligand JL, Feron O, Kelly RA . Role of nitric oxide in myocardial function. In: Ignarro LJ (ed). Nitric Oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 585–607.

    Chapter  Google Scholar 

  18. Wegner HE, Knispel HH, Klan R, Miller K . Efficacy of linsidomine chlorohydrate, a direct nitric oxide donor, in the treatment of human erectile dysfunction: results of a double-blind cross over trial. Int J Impot Res 1995; 7: 233–237.

    CAS  PubMed  Google Scholar 

  19. Moody JA, Vernet D, Laidlaw S, Rajfer J, Gonzalez-Cadavid NF . Effects of long-term oral administration of L-arginine on the rat erectile response. J Urol 1997; 158: 942–947.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study has been supported by a grant from Baskent University (KA: 04/26).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Peskircioglu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Peskircioglu, L., Atac, F., Erdem, S. et al. The association between intron 4 VNTR, E298A and IVF 23+10 G/T polymorphisms of ecNOS gene and sildenafil responsiveness in patients with erectile dysfunction. Int J Impot Res 19, 149–153 (2007). https://doi.org/10.1038/sj.ijir.3901501

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901501

Keywords

This article is cited by

Search

Quick links